Citius Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights
Citius Pharmaceuticals Inc share price today is $0.5151, up -2.07%. The stock opened at $0.5201 against the previous close of $0.5313, with an intraday high of $0.53195 and low of $0.5033.
Citius Pharmaceuticals Inc Share Price Chart
Citius Pharmaceuticals Inc
Citius Pharmaceuticals Inc Share Price Performance
Citius Pharmaceuticals Inc Institutional Holdings
Citius Pharmaceuticals Inc Market Status
Citius Pharmaceuticals Inc Fundamentals
Market Cap 14.59 M
PB Ratio 0.2493
PE Ratio 0.0
Enterprise Value 10.80 M
Total Assets 130.94 M
Volume 176710
Citius Pharmaceuticals Inc Company Financials
About Citius Pharmaceuticals Inc & investment objective
Company Information Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Organisation Biotechnology
Employees 23
Industry Biotechnology
CEO Mr. Leonard L. Mazur
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Citius Pharmaceuticals Inc FAQs
What is the share price of Citius Pharmaceuticals Inc today?
The current share price of Citius Pharmaceuticals Inc is $0.5151.
Can I buy Citius Pharmaceuticals Inc shares in India?
Yes, Indian investors can buy Citius Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Citius Pharmaceuticals Inc shares in India?
You can easily invest in Citius Pharmaceuticals Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Citius Pharmaceuticals Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Citius Pharmaceuticals Inc.
Can I buy fractional shares of Citius Pharmaceuticals Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Citius Pharmaceuticals Inc?
Citius Pharmaceuticals Inc has a market cap of $14.59 M.
In which sector does Citius Pharmaceuticals Inc belong?
Citius Pharmaceuticals Inc operates in the Biotechnology sector.
What documents are required to invest in Citius Pharmaceuticals Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Citius Pharmaceuticals Inc?
The PE ratio of Citius Pharmaceuticals Inc is N/A and the PB ratio is 0.25.